-
Add to Cart The item has been added19640-5A nonpeptide renin inhibitor (IC<sub>50</sub> = 0.6 nM) that selectively binds to the S3 sub-pocket of renin, preventing the conversion of angiotensinogen to angiotensin I, thereby blocking eventual conversion to angiotensin II reduces blood -
Add to Cart The item has been addedA9600-1 mgThomas Scientific
ALK and IGF-1R inhibitor. It alters ERK/Akt/STAT3 signaling, suppresses cell proliferation, and induces regression or stasis in tumor models. (C08-0488-609)
Price: $172.48List Price: $191.65AZD-3463 is an inhibitor of anaplastic lymphoma kinase (ALK) and insulin-like growth factor 1 receptor (IGF-1R). This compound exhibits anticancer chemotherapeutic activity, inhibiting proliferation by altering downstream ERK/Akt/STAT3 signaling. -
Add to Cart The item has been addedA9600-5 mgThomas Scientific
ALK and IGF-1R inhibitor. It alters ERK/Akt/STAT3 signaling, suppresses cell proliferation, and induces regression or stasis in tumor models. (C08-0488-995)
Price: $282.32List Price: $313.69AZD-3463 is an inhibitor of anaplastic lymphoma kinase (ALK) and insulin-like growth factor 1 receptor (IGF-1R). This compound exhibits anticancer chemotherapeutic activity, inhibiting proliferation by altering downstream ERK/Akt/STAT3 signaling. -
Add to Cart The item has been addedA9600-25 mgThomas Scientific
ALK and IGF-1R inhibitor. It alters ERK/Akt/STAT3 signaling, suppresses cell proliferation, and induces regression or stasis in tumor models. (C08-0489-512)
Price: $621.63List Price: $690.71AZD-3463 is an inhibitor of anaplastic lymphoma kinase (ALK) and insulin-like growth factor 1 receptor (IGF-1R). This compound exhibits anticancer chemotherapeutic activity, inhibiting proliferation by altering downstream ERK/Akt/STAT3 signaling. -
Add to Cart The item has been addedA7400-1 mgThomas Scientific
ALK inhibitor. It decreases tumor burden in lung and intrapleural tumor models. (C08-0488-656)
Price: $179.76List Price: $199.73ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models. -
Add to Cart The item has been addedA7400-5 mgThomas Scientific
ALK inhibitor. It decreases tumor burden in lung and intrapleural tumor models. (C08-0488-971)
Price: $317.77List Price: $353.07ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models. -
Add to Cart The item has been addedA7400-25 mgThomas Scientific
ALK inhibitor. It decreases tumor burden in lung and intrapleural tumor models. (C08-0489-539)
Price: $663.84List Price: $737.60ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models. -
Add to Cart The item has been added18775-1A potent inhibitor of ALK (IC<sub>50</sub> = 0.07 nM) that is less effective at IGF-1R and InsR (IC<sub>50</sub>s = 3.
-
Add to Cart The item has been added18775-10A potent inhibitor of ALK (IC<sub>50</sub> = 0.07 nM) that is less effective at IGF-1R and InsR (IC<sub>50</sub>s = 3.
-
Add to Cart The item has been added18775-5A potent inhibitor of ALK (IC<sub>50</sub> = 0.07 nM) that is less effective at IGF-1R and InsR (IC<sub>50</sub>s = 3.
-
Add to Cart The item has been added18775-50A potent inhibitor of ALK (IC<sub>50</sub> = 0.07 nM) that is less effective at IGF-1R and InsR (IC<sub>50</sub>s = 3.
-
Add to Cart The item has been added15526-1A selective inhibitor of the TGF-&beta type 1 receptor ALK5 (IC<sub>50</sub>s = 4, 18, and 23 nM for ALK5 autophosphorylation, TGF-&beta cellular assay, and ALK5 binding in HepG2 cells, respectively) used to induce stem cell pluripotency by
